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ABSTRACT
MPMV has great potential for development as a vector for gene therapy. In this respect, precisely defining the sequences and
structural motifs that are important for dimerization and packaging of its genomic RNA (gRNA) are of utmost importance.
A distinguishing feature of the MPMV gRNA packaging signal is two phylogenetically conserved long-range interactions (LRIs)
between U5 and gag complementary sequences, LRI-I and LRI-II. To test their biological significance in the MPMV life cycle,
we introduced mutations into these structural motifs and tested their effects on MPMV gRNA packaging and propagation.
Furthermore, we probed the structure of key mutants using SHAPE (selective 2′hydroxyl acylation analyzed by primer
extension). Disrupting base-pairing of the LRIs affected gRNA packaging and propagation, demonstrating their significance to
the MPMV life cycle. A double mutant restoring a heterologous LRI-I was fully functional, whereas a similar LRI-II mutant
failed to restore gRNA packaging and propagation. These results demonstrate that while LRI-I acts at the structural level,
maintaining base-pairing is not sufficient for LRI-II function. In addition, in vitro RNA dimerization assays indicated that the
loss of RNA packaging in LRI mutants could not be attributed to the defects in dimerization. Our findings suggest that U5-gag
LRIs play an important architectural role in maintaining the structure of the 5′ region of the MPMV gRNA, expanding the
crucial role of LRIs to the nonlentiviral group of retroviruses.
Keywords: retroviruses; Mason-Pfizer monkey virus (MPMV); RNA secondary structure; RNA packaging and dimerization;
long-range interactions (LRI); SHAPE (selective 2′hydroxyl acylation analyzed by primer extension)
INTRODUCTION
One of the hallmarks of the retroviral life cycle is the efficient
and specific packaging of the genomic RNA (gRNA) as di-
mers by the assembling virus particles (for review, see
Paillart et al. 2004a). During this process, full-length,
unspliced gRNA is preferentially packaged, whereas spliced
viral and cellular RNAs are generally excluded from the na-
scent virus particles. The packaging specificity results from
high-affinity interactions between the retroviral viral nucleo-
capsid domain (NC) within the Gag precursor and a specific
sequence at the 5′ end of the viral genome called the packag-
ing signal (psi,Ψ; for review, see D’Souza and Summers 2005;
Lever 2007; Johnson and Telesnitsky 2010). Determinants of
retroviral gRNA dimerization and packagingmap to the same
100 to 400 nucleotides (nt) at the 5′ end of the gRNA; there-
fore, it is not surprising that packaging signals are located
within the dimer linkage structure (DLS) that is formed
when two gRNAs dimerize. A number of studies undertaken
to identify the packaging determinants of retroviruses have
shown that packaging sequences are generally present down-
stream from the major splice donor (mSD) (for review, see
D’Souza and Summers 2005; Lever 2007; Johnson and
Telesnitsky 2010). Therefore, a simplistic model would sug-
gest that the full-length unspliced genomic RNA is preferen-
tially packaged by virtue of the presence of the packaging
determinant following interaction with the NC binding site
(for review, see D’Souza and Summers 2005; Lever 2007;
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Johnson and Telesnitsky 2010). On the other hand, the pack-
aging sequences are eliminated during splicing, thereby ex-
cluding the spliced RNAs from encapsidation into the
nascent viral particles. However, in the case of HIV-1, the
main determinant of Gag binding, stem–loop 1 (SL1) is lo-
cated upstream of the major splice site (Abd El-Wahab
et al. 2014; Smyth et al. 2015) and is thus present in both
the spliced and unspliced viral mRNA, revealing amore com-
plex mechanism of gRNA selection in which the gRNA struc-
ture plays a key role (Abd El-Wahab et al. 2014; Smyth et al.
2015). A similar situation also prevails in HIV-2 as both the
spliced and unspliced viral mRNAs contain the packaging de-
terminants, yet only the unspliced messages are encapsidated
into the virus particle (for review, see Balvay et al. 2007).
Despite the fact that RNA packaging is a universal step in
all retroviruses and the packaging signals are found at the 5′
end of the retroviral gRNAs, no sequence conservation has
been found between the packaging signals of different retro-
viruses. Moreover, it is becoming evident from cross-packag-
ing studies that switching the packaging sequences between
two different retroviruses that have no primary sequence ho-
mology can maintain efficient packaging (Rizvi and Pangani-
ban 1993; Yin and Hu 1997; White et al. 1999; Parveen et al.
2004; Moore et al. 2007; Al Dhaheri et al. 2009; Al Shamsi
et al. 2011). The process of gRNA packaging thus seems to
involve recognition of the structure rather than the sequence
of the packaging signals. Consistent with these observations,
packaging sequences of almost all retroviruses assume high-
er-order structures comprising several structural motifs
(for review, see D’Souza and Summers 2005; Lever 2007;
Johnson and Telesnitsky 2010). However, the significance
of these structural motifs to gRNA packaging remains largely
unclear. One such characteristic feature of retroviral gRNA
packaging signals is the long-range interaction (LRI) involv-
ing sequences in R/U5 that are complementary to a sequence
found downstream in the gag gene (Paillart et al. 2002, 2004b;
Abbink and Berkhout 2003; Kenyon et al. 2008; Song et al.
2008; Jaballah et al. 2010; Aktar et al. 2013, 2014).
Genomic RNA packaging and dimerization among retro-
viruses are being intensively investigated, in part because
of their use in human gene therapy. Among retroviruses,
HIV-1-based vectors are being exploited currently; however,
their use in humans raises critical safety concerns. Vectors
from phylogenetically distant, nonhuman retroviruses such
as Mason-Pfizer monkey virus (MPMV) may circumvent
such safety concerns. The use of MPMV-based vectors are
also being considered ideal since MPMV promoter is tran-
scriptionally active in human cells and expression of the ther-
apeutic genes of interest may require nuclear export signals
like the MPMV constitutive transport element (CTE) (Bray
et al. 1994) for their efficient expression. These unique fea-
tures have led to increasing interest in developing MPMV
vectors for human gene therapy. However, before MPMV-
based vectors can be used in humans, it is crucial that themo-
lecular mechanisms of pertinent aspects of their life cycle be
fully understood. Due to these reasons, among β retroviruses,
MPMV is the most extensively studied in terms of its gRNA
packaging and dimerization.
Initial RNA packaging studies have identified a stretch of
nucleotides at the 5′ end of the MPMV genome important
for incorporation of its RNA into the nascent virus particles
(Vile et al. 1992; Harrison et al. 1995; Guesdon et al. 2001).
Later, a more systematic mutational analysis of the 5′ end
of the viral genome revealed that the packaging determinants
of MPMV are multipartite and reside in two distinct regions:
region “A” which includes the first 50 nts of the 5′ untrans-
lated region (UTR); and region “B” that encompasses the
last 23 nt of the 5′ UTR as well as the first 120 nt of gag
(Schmidt et al. 2003; Jaballah et al. 2010). RNA secondary-
structure predictions of this region suggested that it assumes
several stable stem–loop structures (Jaballah et al. 2010). The
predicted structure was later validated by using selective 2′
hydroxyl acylation by primer extension (SHAPE) (Fig. 1;
Aktar et al. 2013).
The SHAPE-validated secondary structure of MPMV
gRNA packaging signal revealed the presence of two LRIs
(LRI-I and LRI-II) (Fig. 1) between U5 and gag complemen-
tary sequences in the region that has been shown to be im-
portant for MPMV gRNA packaging (Schmidt et al. 2003;
Jaballah et al. 2010). These LRIs are phylogenetically con-
served among different strains of MPMV both at the se-
quence and secondary structural levels (Aktar et al. 2013),
suggesting that these two LRIs could play a role in gRNA
packaging, potentially by maintaining the overall secondary
structure of the gRNA packaging signal. Therefore, to pro-
vide functional and structural evidence for the existence of
U5-gag LRIs and establish their biological significance during
theMPMV life cycle, we introduced a series of mutations and
tested their effects on MPMV gRNA packaging and propaga-
tion using a biologically relevant trans-complementation as-
say (Supplemental Fig. 1), while the structure of selected key
mutants was analyzed by SHAPE.
RESULTS
Experimental approach
The sequences involved in formation of the U5-gag LRIs fall
in a region that has been reported to be important for both
MPMV RNA packaging and dimerization and have been
shown to extend into gag (Schmidt et al. 2003; Jaballah
et al. 2010; Aktar et al. 2013). Therefore, it is difficult to
test the effects of mutations in U5-gag LRIs in the full-length
genomic context as mutations introduced in this region
might affect Gag/Pol protein synthesis. To overcome such a
caveat, we used the three-plasmid trans-complementation as-
say developed in our laboratory for MPMV (Browning et al.
2001). It provides the necessary biological components to
generate virus particles containing the packaged RNA, the
replication of which is limited to a single round because
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reinfection of the target cells cannot take place (Supplemental
Fig. 1; Browning et al. 2001). The Gag and Gag/Pol proteins
were provided in trans from a separate expression plasmid.
Briefly, the wild-type (SJ2) or mutant transfer vectors, the
Gag/Pol packaging construct (TR301), and the envelope ex-
pressing plasmid (MD.G), along with a firefly luciferase ex-
pression plasmid (pGL3C), were cotransfected into the
producer 293T cells. The resulting virus particles were used
to isolate and quantify the packaged RNA and to monitor
its propagation in the infected HeLa T4 cells following their
transduction with the marker hygromycin-resistant gene.
The number of resulting hygromycin-resistant colonies
should be directly proportional to the packaged RNA con-
tent, providing an indirect estimate of RNA packaging effi-
ciency (Supplemental Fig. 1).
A custom-made qPCR assay was developed for quantita-
tion of wild-type or mutant MPMV RNA both in the cyto-
plasm as well as in the virions (see Materials and Methods)
that employed a probe along with primers that bound within
the U5/PBS region of MPMV (nucleo-
tides 702–770). This region is common
to the wild-type and mutant transfer vec-
tor RNAs and away from the site of the
mutations, ensuring 100% complemen-
tary binding efficiency of the primers
and probe to the target sites. A human
β-actin assay was used as an endogenous
control, as described previously (Mustafa
et al. 2012; Aktar et al. 2014).
Possible role of the wobble guanine–
uracil (G•U) base pairs in LRI-I and
LRI-II during MPMV RNA packaging
and propagation
Sequence analysis of the U5-gag LRI-I
revealed that out of the 13 pairs of com-
plementary nucleotides, four are wob-
ble guanine–uracil (G•U) base pairs
(Fig. 1). Since the LRI sequences play a
role in anchoring the RNA structure
(Jaballah et al. 2010; Aktar et al. 2013),
we reasoned that further strengthening
the base-pairing between the U5 and
gag sequences of the LRI-I could stabilize
its structure, resulting in enhanced RNA
packaging. Thus, mutant RK1was created
in which the four G•U base pairs of LRI-I
were substituted by more stable G = C
base pairs (Fig. 2A). Similarly, mutant
RK2 was created in which all the six
G•U base pairs in both LRIs were con-
verted into G = C base pairs (Fig. 2A).
The three-plasmid trans-complemen-
tation assay was used to test the effects
of the introduced mutations on vector RNA packaging and
propagation. Following transfection, cells were fractionated
into cytoplasmic and nuclear fractions to assess vector RNA
expression and nuclear export. RNA isolated from both the
cytoplasmic fractions and pelleted viral particles was
DNase-treated and PCR-amplified using MPMV vector-spe-
cific primers. The absence of amplification product con-
firmed the absence of DNA contamination in these RNA
preparations (Fig. 2B.I and II). The integrity of the nucleocy-
toplasmic fractionation was confirmed by demonstrating the
absence of unspliced β-actin mRNA in the cytoplasmic frac-
tions (Fig. 2B.III) and the presence of spliced β-actin mRNA
in these fractions (Fig. 2B.IV). The unspliced β-actin ampli-
fications were performed as a multiplex PCR in the presence
of primers/competimer for 18S ribosomal RNAs and suc-
cessful amplification of 18S ribosomal RNAs across all the
samples validated the presence of amplifiable cDNAs (Fig.
2B.III). Finally, cDNAs prepared from cytoplasmic RNA
fractions were amplified using MPMV transfer vector-
FIGURE 1. SHAPE-validated structure of MPMV packaging signal RNA. (A) RNA structure of
MPMV packaging signal after applying SHAPE constraints. Nucleotides are color-coded as per
the SHAPE reactivity key. Arrows point to important structural elements of the virus genome.
The solid boxed regions show the two long-range interactions (LRIs), LRI-I and LRI-II, observed
in the structure. The SHAPE-validated structure corroborates well with the predicted structure
except for subtle differences in LRI-II (the predicted LRI-II structure shown in the enlarged
dashed box). A uridine residue (U62) is unpaired and forms a bulge in the SHAPE-validated,
but not in the predicted LRI-II structure, while C65 is base-paired in the SHAPE-validated struc-
ture, but unpaired in the predicted structure (figure adapted with permission from Aktar et al.
2013). (B) Schematic representation of MPMV subgenomic transfer vector, SJ2 (Jaballah et al.
2010), in which region between R and 120 nt of Gag that has been shown to be important for
MPMV RNA packaging and dimerization is demarcated. The same region was used to predict
and validate the RNA secondary structure.
Long-range interactions and retroviral RNA packaging
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specific primers to ensure that the transfer vector RNAs were
efficiently expressed and properly transported from the nu-
cleus to the cytoplasm (Fig. 2B.V).
Next, we analyzed the packaging efficiencies of RK1 and
RK2 mutant RNAs in virus particles using the custom-de-
signed qPCR real-time assay, as described in Materials and
Methods. The viral RNA packaging results obtained were fur-
ther normalized to their cytoplasmic expression (Fig. 2C.I),
the transfection efficiency (data not shown), and the packag-
ing of the wild-type (SJ2) RNA to determine the relative
packaging efficiency (RPE) of each mutant RNA (Fig. 2C.
II). In contrast to our expectations, the RPE of the RK1
and RK2 mutants designed to stabilize the LRIs was actually
reduced (2.8-fold and fourfold, respectively; P < 0.01; Fig.
2C.II). In agreement with the RNA packaging data, these mu-
tants were also defective for RNA propagation (Fig. 2C.III).
These effects on RNA packaging and propagation were ob-
served despite the fact that the transfection efficiencies of
the RK1 and RK2 mutants and wild-type (SJ2) in multiple
experiments were within twofold of each other (data not
shown), while real-time qPCR analysis of mutant transfer
vector RNAs showed similar levels of expression in the cyto-
plasm to the wild-type, SJ2 (Fig. 2C.I).
Role of the LRI-I structure in MPMV RNA
packaging and propagation
To investigate the complementary nature of the U5-gag
LRI-I sequences, we deleted either the U5 (X-I; RK3) or
gag (Y-I; RK4), or both U5 and gag sequences (RK5)
while maintaining LRI-II (Fig. 2A). The dual mutation in
RK5 was introduced to determine whether MPMV could
FIGURE 2. Effect of substitution/deletion mutations in U5-gag LRIs on MPMV gRNA packaging and propagation. (A) Table outlining the substi-
tution/deletion mutations introduced into the U5-gag sequences of LRI-I and LRI-II. Sequences of the mutations introduced are represented in lower
case and in red. In RK2, (∗) denotes that only part of the U5 sequence for both LRIs is shown due to space limitations. (B) Representative gel images of
the controls needed for validating different aspects of the three-plasmid in vivo packaging and propagation assay: (I and II) PCR amplification of
DNase-treated RNA from the cytoplasmic and viral RNA preparations, respectively, withMPMV-specific vector primers; (III) multiplex amplification
of unspliced β-actin mRNA and 18S rRNA; (IV) PCR amplification of spliced β-actin mRNA to check for the nucleocytoplasmic fractionation tech-
nique; and (V) PCR amplification of transfer vector cytoplasmic cDNAs using MPMV vector-specific primers. (C) Bar graphs represent: (I) the rel-
ative cytoplasmic expression of transfer vector RNAs in 293T cells relative to the wild-type (SJ2 vector) after normalization with the β-actin
endogenous control and luciferase expression; (II) packaging efficiency of the mutant transfer vector RNAs relative to SJ2 after normalization
with β-actin and luciferase expression; and (III) the relative propagation of MMTV transfer vector RNAs as measured by the luciferase-normalized
hygromycin-resistant colony-forming units (CFU)/mL for mutant transfer vectors compared to the wild-type SJ2 vector. The data represented in the
histograms correspond to the mean of samples tested in triplicates (±SD) following transfection and infection experiments.
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package its RNA in the absence of LRI-I while maintaining
only LRI-II.
These mutant transfer vectors (RK3-RK5) were tested in
the in vivo packaging and propagation assays. Figure 2B,C.I
details the necessary controls (DNase treatment of RNA,
nucleocytoplasmic fractionation control, presence of amplifi-
able cDNA, and successful expression and cytoplasmic trans-
port of vector RNAs) followed by quantitation of the
packaging potential of RNAs into nascent virions. These
analyses demonstrated that deletion of either one (U5-X-
I in RK3 or gag-Y-I in RK4) or both complementary sequenc-
es (RK5) involved in LRI-I almost abolished RNA packaging
(>10-fold compared to the wild-type; Fig. 2C.II). Consistent
with RPEs, the propagation efficiencies of these mutant
RNAs were also dramatically reduced (Fig. 2C.III).
To establish whether base-pairing between the comple-
mentary U5 and gag sequences forming LRI-I is sufficient
to promote gRNA packaging or whether the native viral se-
quences (U5 and gag) are required, two additional mutants
were generated. We substituted either the U5 (X-I) sequence
to disrupt LRI-I base-pairing (Fig. 2A, mutant RK6), or both
the U5 (X-I) and gag (Y-I) sequences to restore it (Fig. 2A,
mutant RK7). Consistent with the deletion mutants RK3-
RK5, disruption of the LRI-I complementarity in RK6 [due
to the substitution of U5 (X-1) sequence with a heterologous
one] almost abolished RNA packaging (>20-fold reduction;
P < 0.01; Fig. 2C.II) and dramatically compromised RNA
propagation (25-fold reduction; P < 0.01; Fig. 2C.III). Resto-
ration of LRI-I with heterologous sequences in RK7 not
only restored RNA packaging, but in fact improved it (Fig.
2C.II), and also restored RNA propagation to wild-type levels
(Fig. 2C.III).
Altogether, data obtained from the test of these mutations
in biological assays demonstrate that complementarity be-
tween the U5 and gag sequences forming LRI-I is crucial
for MPMV RNA packaging and propagation. These results
also show that the mere presence of LRI-II is not sufficient
to encapsidate MPMV RNA into the budding virus particles.
Role of LRI-II in MPMV RNA packaging
and propagation
A similar mutational approach was used toward investigating
the role of U5-gag complementary sequences forming LRI-II
(Fig. 3A). LRI-II was disrupted in mutants RK8, RK9, RK10,
RK12, and RK13 as a result of deletion of U5 (X-II: mutant
RK12) or various substitutions of either U5 (X-II: RK8,
RK9, RK13) or gag (Y-II: RK10). After performing all the
necessary controls (Fig. 3B,C.I), these substitution and dele-
tion mutants (RK8-RK10, RK12, and RK13) were tested in
the in vivo packaging and propagation assays. Similar to our
observations with regard to LRI-I, RNA packaging and prop-
agationof thesemutants were nearly ablated (Fig. 3C.II,C.III).
We next attempted to design mutants that would restore a
heterologous wild-type-like LRI-II structure by simultane-
ously substituting the U5 (X-II) and gag (Y-II) sequences
with each other to restore complementarity using native se-
quences in reverse. However, the U5 and gag sequences form-
ing LRI-II differed somewhat between the predicted and
SHAPE-validated secondary structure models of MPMV
packaging signal RNA (Aktar et al. 2013). Specifically, the
uridine (U) residue at position 62 (U62) forms a G•Uwobble
base pair in the predicted structure, whereas it forms a bulge
in the SHAPE-validated structure (Fig. 1; Jaballah et al. 2010;
Aktar et al. 2013). In addition, cytosine at position 65
(C65) that was not originally predicted to be part of the U5
(X-II) complementary sequences was included in the
SHAPE-validated LRI-II structure. As a result, the U5
(X-II) sequence became 9 nt long instead of 8 nt as predicted
earlier (Fig. 1; Jaballah et al. 2010; Aktar et al. 2013). Thus,
we designed two complementary mutants, RK11, which
should restore the predicted LRI-II structure, and RK14,
which should restore the SHAPE-validated LRI-II structure
(Fig. 3A).
Quite surprisingly, packaging of both RK11 and RK14
RNAs was severely affected (Fig. 3C.II). In line with these re-
sults, propagation of RK11 and RK14 RNAs was also dramat-
ically reduced (Fig. 3C.III). These results suggest that either
the wild-type complementary sequences of U5 (X-II) and
gag (Y-II) are required for LRI-II function, or that the LRI-
II structure was not restored in these mutants, contrary to
our expectations. It was therefore important to experimen-
tally test the structure of these mutants.
Structural analyses of the mutant transfer
vector RNAs
In an attempt to perform a structure/function relationship of
the MPMV gRNA packaging signal, all mutants were ana-
lyzed using the Mfold software (Mathews et al. 1999; Zuker
2003) to predict their thermodynamically most stable struc-
tures. While mutants predicted to destabilize the LRI struc-
tures are likely to do so, it is more difficult to correctly
predict the structures of mutants designed to stabilize or to
restore the LRI-I/II structures, as sequence alterations offer
alternative base-pairing possibilities. Therefore, we analyzed
the structures of key LRI-I and II mutant transfer vector
RNAs using SHAPE.
Structure–function relationship of the stabilizing
mutations in U5-gag LRI-I and LRI-II
The Mfold predictions of the secondary structures of U5-gag
LRI-I and LRI-II mutants with G•U base pairs, RK1 and RK2,
did not reveal any disruptions of LRIs when compared to the
wild-type, even though there was a significant decrease
(three- to fourfold) in RPE of these mutants (Supplemental
Fig. 2). As expected, the substitution of G•U base pairs with
G = C pairs stabilized the predicted secondary structures by
10 and 16 kcal/mol, respectively (Supplemental Fig. 2B,C).
Long-range interactions and retroviral RNA packaging
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To experimentally validate these predictions, we performed
SHAPE on an in vitro transcribed RNA corresponding to
the first 550 nt of RK1 gRNA, and the SHAPE data (Supple-
mental Table 1) were applied as constraints in the structure
prediction program RNAstructure (version 5.3) (Reuter
and Mathews 2010). Of the five most likely RK1 structures,
after taking into account the SHAPE data, four predicted
the existence of both LRI-I and LRI-II, and one predicted
the existence of LRI-I, but not LRI-II. The second of these
SHAPE-validated structures was similar to the wild-type
SHAPE-validated structure (Supplemental Fig. 2D). Howev-
er, careful inspection of the SHAPE reactivity of the nucleo-
tides predicted to be involved in LRI-I and LRI-II strongly
argues against the existence of LRI-I in mutant RK1. Several
nucleotides in the X-I (U5) sequences (i.e., A44, C45, C50,
G51, U52, and G53) were more reactive in RK1 than in the
wild-type MMPV strain, whereas only 1 nt (C48) was less re-
active in the RK1 mutant (Fig. 4A,B). The observed reactivity
pattern of RK1 was thus at odds with the predicted stabiliza-
tion of LRI-I. Besides that, the reactivity of the Y-I (gag) se-
quence was only marginally affected in mutant RK1, except
for strong reverse transcription pausing at nucleotides
G334, G335, G336, G338, and U339, which prevented deter-
mination of the reactivity of these residues (Fig. 4A,B). These
pausing sites, which were not observed with the wild-type
gRNA, suggest that the Y-I (gag) sequence is involved in dif-
ferent structures in thewild-type andRK1 gRNAs. Altogether,
these data strongly suggest that LRI-I does not exist in
FIGURE 3. Effect of deletion/substitution mutations introduced into U5-gag LRI-II on MPMV gRNA packaging and propagation. (A) Table out-
lining the deletion/substitution mutations introduced into the U5-gag sequences of LRI-II. Sequences of the introduced mutations are represented
in lower case and in red. Two sets of mutants are outlined in the table. The first set of mutations were introduced into the Mfold-predicted 8-nt
LRI-II structure, while the second set describes mutations introduced into the SHAPE-validated 9-nt LRI-II structure. (∗) Denotes the 8-nt U5 se-
quence of the predicted LRI-II. (∗∗) Denotes the 9-nt U5 sequence of the SHAPE-validated LRI-II. (B) Representative gel images of the controls needed
for validating different aspects of the three-plasmid in vivo packaging and propagation assay: (I and II) PCR amplification of DNase-treated RNA from
the cytoplasmic and viral RNA preparations, respectively, with MPMV-specific vector primers; (III) multiplex amplification of unspliced β-actin
mRNA and 18S rRNA; (IV) PCR amplification of spliced β-actin mRNA to check for the nucleocytoplasmic fractionation technique; and (V)
PCR amplification of transfer vector cytoplasmic cDNAs using MPMV vector-specific primers. (C) Bar graphs represent: (I) the relative cytoplasmic
expression of transfer vector RNAs in 293T cells relative to the wild-type (SJ2 vector) after normalization with the β-actin endogenous control and
luciferase expression; (II) packaging efficiency of the mutant transfer vector RNAs relative to SJ2 after normalization with β-actin and luciferase ex-
pression; and (III) the relative propagation of MMTV transfer vector RNAs as measured by the luciferase-normalized hygromycin resistant colony-
forming units (CFU)/mL for mutant transfer vectors compared to the wild-type SJ2 vector. The data represented in the histograms correspond to the
mean of samples tested in triplicates (±SD) following transfection and infection experiments.
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mutant RK1 even though predicted otherwise. By compari-
son, little difference was found between wild-type and RK1
RNA when looking at the X-II and Y-II sequences forming
LRI-II (Fig. 4A,B). The only significant difference was a de-
creased reactivity of U61 and a concomitant reactivity in-
crease of U62. Similar changes were observed with the
other mutants (see below); they suggest that either U61 or
U62 can base-pair with G274 and that unlike LRI-I, LRI-II
is formed in mutant RK1. Considering this structural infor-
mation, the gRNA packaging and propagation defects of
RK1 are most likely due to the disruption
of LRI-I, in line with the results we ob-
tained with mutants RK3, RK4, RK5,
and RK6 (see below).
Structure–function relationship
of U5-gag LRI-I
The predicted structures of mutants RK3
and RK5 showed that whenever the U5
(X-I) sequence was deleted, both LRI-I
and LRI-II structures were lost, in addi-
tion to the gag stem–loop 1, SL1 (Supple-
mental Fig. 3B,D). In RK4, deletion of
the gag (Y-I) sequence affected LRI-I
and gag SL1, while LRI-II remained in-
tact (Supplemental Fig. 3C). All three
mutations resulted in a complete loss of
RNA packaging and propagation, sug-
gesting that the maintenance of LRI-I
structure is critical for these functions.
Mutants RK6 and RK7 were created to
destabilize and reestablish the LRI-I
structure, respectively. As shown in Sup-
plemental Figure 4B, the predicted struc-
ture of RK6 revealed loss of the LRI-I
stem, but maintenance of all the other
important structural motifs. The muta-
tion introduced in RK7, on the other
hand, predicted restoration of the LRI-I
structure (Supplemental Fig. 4C). We
performed SHAPE on mutants RK6
and RK7 to experimentally validate these
predicted structures (Fig. 4C,D; Supple-
mental Table 1). Among the five most
likely RK6 structures incorporating the
SHAPE data, none predicted the exis-
tence of LRI-I, while two predicted dis-
ruption of LRI-II. Examination of the
SHAPE reactivity of the sequences poten-
tially involved in LRI-I/II supports the
existence of LRI-II (Fig. 4C). Several nu-
cleotides in U5 (X-1) were more reactive
in RK6 than in the wild-type RNA (i.e.,
U45, A51, U52, A53, U54, and A55), consistent with disrup-
tion of LRI-I. The gag (Y-I) sequence remained weakly reac-
tive, with the exception of U339, indicating that this
sequence is base-paired elsewhere in the RK6 structure. The
only significant reactivity change in LRI-II was a decrease in
reactivity of U61 and a concomitant increase in reactivity of
U62 in RK6 compared to the wild-type (Fig. 4C). This change
is compatible with the existence of LRI-II, except that U62,
rather than U61 is bulging out in the mutant structure.
Importantly, the SHAPE-validated RK6 structure maintained
FIGURE 4. SHAPE reactivity of the region corresponding to LRI-I/II and Gag SL1 of wild-type
and mutant (RK1, RK6, and RK7) gRNAs. The SHAPE reactivity is color-coded on the SHAPE-
validated structure of wild-type and mutant RNAs. (A–D) The SHAPE reactivity is reported on
the wild-type structure for the sake of comparison. For mutants RK1, RK6, and RK7, a structure
similar to the wild-type structure is drawn to facilitate comparison of the SHAPE reactivity, but
this structure does not necessarily reflect the actual structure (see text and Fig. 5 for details). The
differences in reactivity in LRI-I and LRI-II in themutants compared to wild-type are indicated by
histograms (red and blue correspond to increase and decrease in reactivity, respectively).
Mutations are highlighted in yellow.
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the SL1, LRI-II, SL2/PBS, pal SL, ssPurine rich region, SL3,
and GagSL1 structural motifs (Fig. 5A), strongly suggesting
that the essentially complete loss of RNA packaging and
propagation of this mutant was a direct result of the disrup-
tion of LRI-I.
The SHAPE data of mutant RK7 (Fig. 4D) reinforced the
predicted structure (Supplemental Fig. 4C) in which the sub-
stituted, heterologous yet complementary U5 (X-I) and gag
(Y-I) sequences restored the LRI-I interaction (Fig. 5B).
The SHAPE reactivity of the sequences involved in LRI-I
and LRI-II also supported the existence of these two long-
range interactions in mutant RK7 (Fig. 4D). While some nu-
cleotides in U5 (X-I) are slightly more reactive in RK7 than in
the wild-type RNA, others were less reactive, keeping the
overall reactivity of the substituted U5 (X-I) similar to the
wild-type sequence. Meanwhile, the reactivity of gag (Y-I)
was not found to be significantly different in the wild-type
and RK7mutant, except for the now familiar strong reactivity
decrease of U61 and the concomitant reactivity increase of
U62 (Fig. 4D). Altogether, our data show that the double sub-
stitution introduced in RK7 restored the wild-type structure
(Figs. 4D, 5B; Supplemental Fig. 4C) and that a heterologous
LRI-I interaction can efficiently support gRNA packaging
and propagation (Fig. 2C.II,III).
Structure–function relationship of the sequences
involved in U5-gag LRI-II
Substitution mutants RK8-RK10 were designed to disrupt
LRI-II, while RK11 was designed to restore LRI-II by flipping
the U5 (X-II) and gag (Y-II) complementary sequences.
Mutants RK8 and RK10 were predicted to adopt structures
that led to the creation of stem structures that somewhat re-
sembled LRI-II but involved different sequences; however,
RNA packaging and propagation of these mutants were still
found to be completely abrogated (Fig. 3C.II,III; Supplemen-
tal Fig. 5). Similarly, mutant RK9 and RK11 were predicted to
create a LRI-II-like stem separated fromLRI-I by a 2-nt bulge,
but both resulted in a complete abrogation of packaging
and propagation (Fig. 3C.II,III; Supplemental Fig. 6). Since
“compensatory” mutant RK11 did not restore RNA packag-
ing, we performed SHAPE on this mutant. None of the four
most likely structures incorporating the SHAPE constraints
actually restored LRI-II, while LRI-I was always present.
The SHAPE reactivity of the sequences potentially involved
in forming LRI-I and II also supports this conclusion (Fig.
6A,B). The nucleotides at both ends of U5 (X-I) were slightly
more reactive in mutant RK11 than in the wild-type, while
the reactivity of the nucleotides in the center was weaker in
the mutant RNA. At the same time, the reactivity of the gag
FIGURE 5. SHAPE-validated RNA secondary structural models of mutant RK6 designed to disrupt LRI-I (A) and RK7 designed to restore LRI-I (B).
Nucleotides are color-coded as per the SHAPE reactivity key. Major structural elements that also exist in wild-type gRNA are labeled as in Figure 1.
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(Y-I) sequence was only marginally affected, supporting
the existence of LRI-I. In contrast, U5 (X-II) and gag (Y-II)
had different reactivity profiles. Nucleotide C61, which is
the equivalent of the bulging out U61 in the wild-type struc-
ture, had a dramatically reduced reactivity, indicating that it is
likely base-paired. Indeed the reactivity of the entire U5
(X-II) was low, strongly suggesting that this 8-nt sequence is
base-paired. On the other hand, the reactivity of nucleotides
U272, U273, and to a lesser extent G274 and U275, increased
in RK11, indicating that the 5′ end of gag (Y-II) is not base-
paired, thus ruling out the existence of the native LRI-II
structure (Fig. 6B). Since LRI-I was maintained in RK11,
its lack of functionality can therefore most likely be attributed
to disruption of LRI-II.
FIGURE 6. SHAPE reactivity of the region corresponding to LRI-I/II and Gag SL1 of wild-type gRNA and mutants RK11, RK13, and RK14. The
SHAPE reactivity is color-coded on the SHAPE-validated structure of wild-type and mutant RNAs. (A–D) The SHAPE reactivity is reported on
the wild-type structure for the sake of comparison. For these mutants, RK11, RK13, and RK14, a structure similar to the wild-type structure is drawn
to facilitate comparison of the SHAPE reactivity, but this structure does not necessarily reflect the actual structure (see text and Fig. 7 for details). The
differences in reactivity in LRI-I and LRI-II in the mutants compared to wild-type are indicated by histograms (red and blue correspond to increase
and decrease in reactivity, respectively). Mutations are highlighted in yellow.
Long-range interactions and retroviral RNA packaging
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Mutants RK12 and RK13 were designed to disrupt
U5-gag complementarity in LRI-II, while RK14 was designed
to restore that complementarity using heterologous se-
quences. Even though these mutations resulted in a complete
abrogation of packaging and propagation (Fig. 3C.II,III),
Mfold predicted that LRI-II should be disrupted in RK12
and RK13, but restored in RK14 (Supplemental Fig. 7). As
function was not restored in mutant RK14 despite recreating
a heterologous LRI-II, we used SHAPE to experimentally an-
alyze the RNA structure of mutants RK13 and RK14. In the
five most likely structures of RK13 that incorporated the
structural information provided by SHAPE, LRI-I was always
formed, and the gag (Y-II) sequence always formed a hairpin,
while the U5 (X-II) sequence base-paired with various se-
quences in gag (Fig. 7A and data not shown). The SHAPE re-
activity of U5 (X-I), gag (Y-I), U5 (X-II), and gag (Y-II)
sequences supports these models. The probing data were
consistent with the existence of LRI-I, even though it was
slightly destabilized at the “left” end (Fig. 6C). U5 (X-II)
was weakly or not reactive, indicating it is base-paired, where-
as the reactivity of the 3′ end of gag (Y-II) indicated that nu-
cleotides A277 and G278 were single-stranded (Fig. 6C). The
reactivity pattern of LRI-I in mutant RK14 was the same as in
RK13,againshowingaslightlydestabilized“left”end(Fig.6D).
The reactivity of U5 (X-II) and gag (Y-II) was compatible
with the existence of a heterologous LRI-II, with the excep-
tion of the A57-U278 base pair, which probably does not ex-
ist, as U278 was highly reactive (Fig. 6D). It should also be
mentioned that the heterologous LRI-II in mutant RK14
does not contain any bulge, in contrast with the SHAPE-val-
idated wild-type LRI-II structure (Fig. 6A,D). Thus, the over-
all SHAPE-validated structure of RK14 is very similar, but not
identical, to the wild-type structure (Fig. 7B and data not
shown). However, this mutant still failed to restore RNA
packaging and propagation (Fig. 3C.II,III), indicating that
maintaining LRI-II base-pairing was not sufficient for
function.
In vitro RNA dimerization on SHAPE-interrogated
LRI mutants
As packaging of retroviral RNA is tightly coupled to its dime-
rization, we next checked if introduced mutations in LRIs af-
fected in vitro RNA dimerization. Wild-type or mutant in
vitro transcribed RNAs were incubated inmonomer or dimer
buffer and analyzed on agarose gel in TBM buffer at 4°C or in
FIGURE 7. SHAPE-validated RNA secondary structure models of mutant RK13 designed to disrupt the complementarity of LRI-II (A) and RK14
designed to restore a heterologous LRI-II (B). Nucleotides are color-coded as per the SHAPE reactivity key. Structural elements that also exist in wild-
type gRNA are labeled as in Figure 1.
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TB buffer at 20°C (see Materials and Methods). While elec-
trophoresis at 4°C in TBM buffer stabilizes the dimer species,
only the most stable dimers survive electrophoresis at 20°C in
the absence of Mg2+ ions (TB buffer). Dimerization of RK1
(LRI-I stabilizing mutant) and RK13 (LRI-II destabilizing
mutant) RNAs was significantly reduced in TB buffer (Fig.
8, top panel), but this reduction (2.2- and 2.5-fold, respective-
ly) is rather modest. Dimerization of the other mutant RNAs
was only slightly affected (<25%). The electrophoresis profile
of mutants RK1, RK11 (mutant with heterologous LRI-II),
and RK13 is qualitatively similar to the wild-type profile,
with one predominant dimer species. There is, however, a
faint band corresponding to a second dimer species that mi-
grated between the monomer and the main dimer species;
this intermediate band is more visible with mutant RK7 (mu-
tant with heterologous LRI-I), and especially with RK6 (LRI-I
destabilizing mutant). Interestingly, this intermediate band is
more predominant when electrophoresis was performed at
20°C in TB (Fig. 8, lower panel), indicating that the dimer
in this intermediate band is more stable than the dimer in
the upper band. Our data also reveal that these two dimer spe-
cies are in equilibrium with each other, as the intermediate
band is usually more pronounced in TB than in TBM buffer.
However, the relative intensity of the top and intermediate
bands does not correlate with RNA packaging: on the one
hand the intermediate band is more pronounced in mutant
RK7 (which restored RNA packaging and propagation; Fig.
2C.II,III) than in wild-type RNA; on the other hand, mutant
RK14 (mutant with heterologous LRI-II), whose dimeriza-
tion profile is qualitatively and quantitatively very similar to
wild-type, is defective at the RNA packaging and propagation
levels (Fig. 3C.II,III). Altogether, these results indicate that
functional loss of RNA packaging of the LRI mutants cannot
be directly correlated to defects in RNA dimerization.
DISCUSSION
One of the distinguishing features of the MPMV packaging
signal RNA secondary structure model based on SHAPE
data is the presence of two LRIs involving 5′ (U5) and 3′
(gag) complementary sequences that are believed to anchor
the structure of the 5′ UTR (Fig. 1; Jaballah et al. 2010;
Aktar et al. 2013). LRIs have been found to be conserved in
several retroviruses, including HIV-1 and 2, simian immuno-
deficiency virus (SIV), feline immunodeficiency virus (FIV),
and mouse mammary tumor virus (MMTV) (Paillart et al.
2002, 2004b; Abbink and Berkhout 2003; Kenyon et al.
2008, 2011; Aktar et al. 2014; Siegfried et al. 2014; Keane
et al. 2015; Smyth et al. 2015; Tran et al. 2015). Despite
the fact that there are substantial sequence heterogeneities
among human, simian, and feline lentiviruses, the preserva-
tion of such LRIs in these lentiviruses suggest they play
important function(s) in the retroviral life cycle (Paillart
et al. 2002; Kenyon et al. 2008, 2011). A pivotal role of
LRIs is further evidenced by the fact that mutations that
destabilize these interactions affect several important steps
in the retroviral life cycle, including RNA packaging and
dimerization (Paillart et al. 2002; Abbink and Berkhout
2003; Song et al. 2008; Rizvi et al. 2010; Lu et al. 2011).
Similarly, an earlier study on MPMV has shown the impor-
tance of gag sequences (involved in maintaining U5-gag
LRIs) in RNA packaging, further arguing in favor of the exis-
tence of LRIs in vivo and their functional role in the MPMV
life cycle (Schmidt et al. 2003).
Unlike other retroviruses with one identified LRI, the
SHAPE-validated MPMV secondary structure model con-
tains two LRIs (LRI-I and LRI-II; Fig. 1), both of whichmain-
tain the interaction between U5 and gag sequences (Aktar
et al. 2013). The functional and SHAPE results we obtained
on a number of LRI mutants validate the existence and bio-
logical significance of LRIs and show that LRI-I could be
functionally replaced by a heterologous LRI, while LRI-II
could not.
All mutations that were designed to disrupt LRI-I (RK3,
RK4, RK5, and RK6) dramatically reduced RNA packaging
and propagation (Figs. 2C, 4C, 5A; Supplemental Figs. 3,
4), demonstrating the functional role of LRI-I. This was espe-
cially true as other motifs, such as pal SL, ssPurine-rich
region, SL3, and Region B, previously shown to be critical
for RNA packaging and dimerization (Jaballah et al. 2010;
Aktar et al. 2014), were preserved in these mutants. Mutant
RK7 was designed to restore a heterologous LRI-I (Supple-
mental Fig. 4C) and SHAPE data supported our structural
predictions (Figs. 4D, 5B). This heterologous LRI-I was fully
functional (Fig. 2C); hence the 13 complementary nucleo-
tides of U5-gag LRI-I of MPMV functionally resembles the
R/U5-gag heptanucleotide of FIV LRI, where a structural mo-
tif rather than a particular sequence has been shown to be es-
sential for RNA packaging (Rizvi et al. 2010).
The wild-type LRI-I and the heterologous LRI-I of mutant
RK7 are moderately stable, as predicted by the predominance
of A–U and G•U base pairs and shown by a significant level of
SHAPE reactivity (Fig. 4A,D). Indeed, it is well known that
the gRNA is an active player in many critical stages in the
FIGURE 8. In vitro RNA dimerization on SHAPE-interrogated LRI
mutants. Wild-type and mutant RNAs were incubated in monomer
(M) or dimer (D) buffer and analyzed by electrophoresis on 1% agarose
gel either in TBM buffer at 4°C (top panel) or in TB buffer at 20°C (lower
panel). Experiments were performed in duplicates and the mean dime-
rization percent is indicated below each lane.
Long-range interactions and retroviral RNA packaging
www.rnajournal.org 915
 Cold Spring Harbor Laboratory Press on June 12, 2017 - Published by rnajournal.cshlp.orgDownloaded from 
retroviral life cycle, including processes that are driven main-
ly by the proper three-dimensional folding of multiple RNA
domains to recruit viral and host factors required for activity.
This structural flexibility is of great functional importance
to the RNA as it is a dynamic structure that undergoes seve-
ral intramolecular and intermolecular interactions during
RNA dimerization and packaging processes (for review, see
D’Souza and Summers 2005; Lever 2007; Johnson and
Telesnitsky 2010). Therefore, even though the LRI-I struc-
ture is important, a limited stability might be required for
function. The RK1 and RK2 mutants designed to test this
possibility did not allow us to answer this question, as careful
inspection of the SHAPE data revealed that LRI-I was not
formed in RK1 (Fig. 4B). Therefore, the strong decrease in
RNA packaging and propagation observed with this mutant
is likely due to disruption of LRI-I, in line with the results
obtained with mutants RK3, RK4, RK5, and RK6 discussed
above. Unexpectedly, when SHAPE data were introduced as
constraints in RNAstructure (Reuter and Mathews 2010)
for RK1, this software still proposed structures in which U5
(X-I) and gag (Y-1) were base-paired, despite the inconsis-
tency with SHAPE data for this region (Supplemental Fig.
2D). There are several plausible reasons why RNAstructure
is unable to propose a secondary structure model that cor-
rectly accounts for the reactivity of U5 (X-I) and gag (Y-1) se-
quences. One possibility is that the actual RK1 RNA structure
is stabilized by a pseudoknot or another higher-order struc-
tural motif that cannot be predicted by the software. An alter-
native explanation could be that the RK1 RNA structure
corresponds to a kinetically trapped conformation during
RNA folding. Such a phenomenon has recently been reported
in the case of the gRNA of a protease defective Moloney
mouse leukemia virus mutant (Grohman et al. 2014). Even
though SHAPE most often does not always propose correct
secondary structure models (Kladwang et al. 2011), our
data show that it is very important to verify experimentally
that “compensatory mutations” actually restore the wild-
type structure. In the absence of such verification, a large pro-
portion of “structure–function relationships” might indeed
turn out to be inaccurate.
LRI-II is also required for function, as all mutants designed
to disrupt it (Figs. 6, 7; Supplemental Figs. 5, 6, 7) displayed
dramatically altered RNA packaging and propagation effi-
ciencies (Fig. 3). Two mutants, RK11 and RK14, were de-
signed to restore a heterologous LRI-II, but according to
structural predictions and SHAPE analysis, LRI-II was
formed in RK14, but not in RK11 (Figs. 6, 7; Supplemental
Figs. 6, 7). Nevertheless, RNA packaging and propagation
of mutant RK14 were severely affected (Fig. 3) despite its
wild-type-like structure (Fig. 7B). Thus, in the case of LRI-
II, base-pairing is not sufficient for function, suggesting
some sequence specificity. This could be the case for instance
if the MPMV Gag precursor directly interacts with LRI-II.
Notably, the heterologous LRI-II does not contain any bulge,
in contrast with the wild-type LRI-II (Figs. 6, 7B). However,
deleting U61 (or U62) in the wild-type sequence did not af-
fect viral propagation (data not shown), indicating that a
bulge is not required for LRI-II function. Finally, SHAPE
data of RK14 designed to restore heterologous LRI-II re-
vealed that nucleotide U278 was highly reactive, precluding
the existence of the A57–U278 base pair (Fig. 6D). As a con-
sequence, the geometry of the junction formed by LRI-I, Gag
SL1, and LRI-II (Fig. 1) was most likely compromised, and
the overall 3D-structure might be significantly altered. The
loss of the native RNA 3D structure may in turn alter, directly
or indirectly, recognition by the Gag precursor.
Indeed, since LRI-I, Gag SL1, and LRI-II involve sequences
within gag downstream from themSD, and are thus restricted
to the full-length unspliced gRNA, this junction represents
a putative Gag binding site. In addition, similar to the pro-
posed role of the HIV-1 U5-AUG LRI in the regulation
of Gag translation (Abbink and Berkhout 2003; Lu et al.
2011), the MPMV LRIs may also have a role in the translation
of the Gag protein since the guanine (G) residue of the gag
AUG start codon is within the gag (Y-II) sequence of LRI-
II. Thus, the MPMV LRIs plausibly could allow the reg-
ulation of a temporal switch between viral protein synthesis
and packaging, conferring high specificity of packaging that
is restricted to the full-length unspliced RNA.
MATERIALS AND METHODS
Genome nucleotide numbering system
The MPMV nucleotide numbering system refers to the genome se-
quence deposited in the Genbank (accession number M12349) by
Sonigo et al. 1986.
Plasmid construction
The packaging construct, TR301, expresses theMPMV gag/pol genes
under the transcriptional control of the human cytomegalovirus
(hCMV) intron A promoter/enhancer described earlier (Browning
et al. 2001; Supplemental Fig. 1A). The vesicular stomatitis virus gly-
coprotein G (VSV-G) expression vector, MD.G, was used to pro-
duce pseudotyped viruses to infect target cells since its receptors
are present on many cell types (Naldini et al. 1996; Supplemental
Fig. 1A).
Substitution and deletion mutations were cloned into the MPMV
sub-genomic transfer vector, SJ2, described previously (Jaballah
et al. 2010), which expresses the hygromycin B phosphotransferase
selectable marker from an internal simian virus 40 early promoter
(SV-Hygr) to monitor the effect of the mutations on propagation
of the packaged viral RNA (Fig. 1B).
The mutations into the LRIs (Figs. 2A, 3A) were introduced using
splice overlap extension (SOE) PCR, requiring two rounds of ampli-
fications, using SJ2 as a template. Round 1 consisted of two indepen-
dent PCRs, A and B in which PCR (A) was performed using the
universal outer forward (sense; S) primer OTR787 (5′-ccctcgagTG
TCCGGAGCCGTGCTGCCCG-3′) along with the inner reverse
(antisense; AS) primer that varied depending upon the mutation
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introduced. In PCR (B), the AS outer primer OTR788 (5′-cccggat
ccTTCTTTCTTATCTATCAATTCTTTAATTAAG-3′) was used along
with the inner S primer which also varied depending upon the
mutations introduced. The resulting PCR products from these
two separate reactions (PCR A and PCR B) contained overlapping
complementary sequences that allowed them to anneal, forming a
template with the introduced mutation for round 2 PCR, which
was performed using outer S and AS primers (OTR787/OTR788),
generating a final product harboring the mutation. The PCR-ampli-
fied mutant products were cleaved with XhoI and BamHI restriction
endonucleases and cloned into similarly digested wild-type transfer
vector, SJ2. This cloning strategy resulted in replacement of the wild-
type sequences, starting from the 5′ end of U3 to 282 bp of gag (Fig.
1), with the PCR-amplified fragments containing the desired muta-
tions. Sequences of primers used for the PCR and cloning are listed
in Supplemental Table 2. The sequence of all mutant clones was ver-
ified by DNA sequencing.
Nucleocytoplasmic fractionation, virion and RNA
isolation, and cDNA preparation
Transfected cells were fractionated into cytoplasmic and nuclear
fractions and RNA extracted as described earlier (Mustafa et al.
2005; Ghazawi et al. 2006; Jaballah et al. 2010; Rizvi et al. 2010).
Packaged viral RNAs were prepared from clarified supernatants
from transfected cultures after filtration through 0.2 µm filters as de-
scribed previously (Mustafa et al. 2005; Ghazawi et al. 2006; Jaballah
et al. 2010; Rizvi et al. 2010). RNA preparations were DNase-treated
and subjected to 30-cycle PCR to test for the presence of any residual
contaminating plasmid DNA using MPMV specific primer pair:
OTR 1161 (S; 5′-GATCAGAACACTGTCTTGTC-3′) and OTR
1163 (AS; 5′-CTT TCTTATCTATCAATTCTTTAA-3′) as described
previously (Jaballah et al. 2010). After confirming the absence of any
plasmid DNA contamination in RNA preparations by PCR, RNAs
were reverse transcribed and PCR amplified to determine the quality
of cDNA preparations. Cytoplasmic cDNAs were amplified for both
unspliced as well as spliced β-actin mRNA to ensure the integrity of
the fractionation process, as described previously (Mustafa et al.
2005; Ghazawi et al. 2006; Jaballah et al. 2010; Rizvi et al. 2010).
Finally, cytoplasmic cDNA preparations were additionally amplified
using MPMV-specific vector primer pair OTR 1161/1163 to ascer-
tain the stability as well as the proper nuclear export of the mutant
transfer vector RNAs.
Real-time quantitative PCR (qPCR) of transfer
vector RNA expression
The relative expression of transfer vector RNAs in the cytoplasm and
their packaging efficiency into the nascently produced virions was
quantified by developing a custom-made Taqman gene expression
assay (Applied Biosystems Inc., ABI). This assay employed a FAM/
MGB-labeled probe along with primers within the U5/PBS region
of MPMV, a region common to the wild-type and the mutant trans-
fer vector RNAs and away from the site of the mutations analyzed in
this study. Although this region is also upstream of the major splice
donor of MPMV, there are no known splice acceptor sites in the
wild-type as well as mutant transfer vectors, including the SV-
Hygro cassette. Therefore, it is unlikely that any splicing will take
place resulting in the generation of spliced RNAs. Such a vector de-
sign has been used successfully in a number of other retroviral sys-
tems for studying genomic RNA packaging efficiencies. In addition,
RNA packaging results obtained from using such assays have corre-
lated well in the past with the RNA propagation data obtained as
measured by the counts of hygromycin-resistant colonies (CFU/
mL) following transduction of the target cells with virus particles
containing packaged RNA (Rizvi et al. 2010; Jaballah et al. 2010;
Mustafa et al. 2012; Aktar et al. 2014).
The assay specifically consisted of a sense primer (5′-CTCCT
CCAGGTTCCTACTGTTGA-3′; nucleotides 702–724), an antisense
primer (5′-TCGTATCCAGCCCCACGTT-3′; nucleotides 770–752),
and a FAM/MGB-labeled probe (5′-TCGGGACAGTTGGC-3′; nu-
cleotides 734–747). The PCR efficiency of the MPMV assay was
calculated using the online PCR efficiency calculator (http://srvgen
.upct.es/index.html; Mallona et al. 2011), which gave a value of
1.86. This value fell slightly below the level suggested for the use
of the ΔΔCTmethod (≥1.9). To ensure that we could use this meth-
od for the relative quantification purposes, the assay was empirically
tested against the standard curvemethod (data not shown) using test
samples with varying amounts of MPMV plasmid DNA. This com-
parative analysis validated the use of the ΔΔCT method for quanti-
tating relative packaging efficiencies.
As an endogenous control, a predesigned VIC/MGB-labeled hu-
man β-actin assay (ABI #4326315E) was used as described previous-
ly (Mustafa et al. 2012; Aktar et al. 2014). Briefly, equal amounts of
cDNAs from the wild-type and mutant samples were amplified for
50 cycles in triplicates for both MPMV and β-actin using the ABI
thermocycler 7500 (ABI). The relative quantification (RQ) values
thus obtained for MPMV expression in both the cytoplasmic and vi-
ral samples were normalized to the luciferase values obtained per μg
protein to control for differences in transfection efficiencies. Finally,
to estimate the packaging efficiency, results obtained for MPMV ex-
pression in the virions were divided by those for the cytoplasmic ex-
pression and then reported relative to the wild-type levels.
In silico and SHAPE analyses of MPMV RNA
secondary structure
The 5′ end of the wild-type andmutantMPMV genomes (region be-
tween R and the first 120 nt of gag) were folded using Mfold
(Mathews et al. 1999; Zuker 2003) to correlate the effects of the in-
troduced mutations on MPMV packaging signal RNA secondary
structure in an attempt to establish structure–function relationship
of this region during MPMV RNA packaging. SHAPE was per-
formed on purified in vitro transcribed wild-type and mutant
MPMV RNAs as previously described (Aktar et al. 2013) using
primers complementary to nucleotides 483–502. Electrophero-
grams were analyzed with the SHAPEfinder program (Vasa et al.
2008; Wilkinson et al. 2008). The SHAPE reactivity data were then
applied as constraints in the structure prediction program RNAs-
tructure (version 5.3; Reuter and Mathews 2010) in order to obtain
the SHAPE-derived RNA structure of the wild-type and mutant
MPMV packaging signal RNAs.
In vitro RNA dimerization assays
In vitro RNA dimerization was performed as previously described
(Aktar et al. 2013). Briefly, 300 nM of wild-type or mutant RNA
was incubated in monomer (50 mM sodium cacodylate at pH 7.5,
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40 mMKCl, 0.1 mMMgCl2) or dimer buffer (50 mM sodium caco-
dylate at pH 7.5, 300 mM KCl, 5 mM MgCl2) for 30 min at 37°C.
After addition of loading buffer, the samples were analyzed on 1%
agarose gels either at 4°C in a TBM buffer (50 mM Tris base, 45
mM boric acid, 0.1 mM MgCl2) or at 20°C TB buffer (50 mM
Tris base, 45 mM boric acid), visualized using ethidium bromide,
and quantified.
Statistical analysis
Statistical analysis was performed employing the standard paired
two-tailed Student’s t-test between the wild-type and the mutant
clones to establish statistical significance. A P-value of 0.01 was con-
sidered to be significant.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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